Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
Schattenberg AV, van de Wiel-van Kemenade E, Bär BM, Geurts van Kessel AH, van der Maazen RW, de Witte TJ. Schattenberg AV, et al. Among authors: van de wiel van kemenade e, van der maazen rw. Ned Tijdschr Geneeskd. 1996 Oct 19;140(42):2087-91. Ned Tijdschr Geneeskd. 1996. PMID: 8965951 Clinical Trial. Dutch.
In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion.
Schattenberg A, Schaap N, Van De Wiel-Van Kemenade E, Bär B, Preijers F, Van Der Maazen R, Roovers E, De Witte T. Schattenberg A, et al. Among authors: van der maazen r, van de wiel van kemenade e. Leuk Lymphoma. 1999 Jan;32(3-4):317-25. doi: 10.3109/10428199909167392. Leuk Lymphoma. 1999. PMID: 10037029 Clinical Trial.
Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donors.
Schattenberg A, van der Meer A, Preijers F, Schaap N, Rinkes M, van der Maazen R, Allebes W, Joosten I, De Witte T. Schattenberg A, et al. Among authors: van der maazen r, van der meer a. Bone Marrow Transplant. 2004 Jun;33(11):1115-21. doi: 10.1038/sj.bmt.1704490. Bone Marrow Transplant. 2004. PMID: 15064694
The Value of IgM Memory B-Cells in the Assessment of Splenic Function in Childhood Cancer Survivors at Risk for Splenic Dysfunction: A DCCSS-LATER Study.
Houtman BM, Walraven I, de Grouw E, van der Maazen RWM, Kremer LCM, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, Tissing WJE, Bresters D, van der Pal HJH, de Vries ACH, Louwerens M, van der Heiden-van der Loo M, Neggers SJC, Janssens GO, Blijlevens NMA, Lambeck AJA, Preijers F, Loonen JJ. Houtman BM, et al. Among authors: van der maazen rwm. J Immunol Res. 2023 Oct 20;2023:5863995. doi: 10.1155/2023/5863995. eCollection 2023. J Immunol Res. 2023. PMID: 37901347 Free PMC article.
84 results